Human brains age less than previously thought
News Mar 05, 2015
Older brains may be more similar to younger brains than previously thought.
In a new paper published in Human Brain Mapping, Biotechnology and Biological Sciences Research Council (BBSRC)-funded researchers at the University of Cambridge and Medical Research Council's Cognition and Brain Sciences Unit demonstrate that previously reported changes in the aging brain using functional magnetic resonance imaging (fMRI) may be due to vascular (or blood vessels) changes, rather than changes in neuronal activity itself.
Given the large number of fMRI studies used to assess the aging brain, this has important consequences for understanding how the brain changes with age and challenges current theories of aging.
A fundamental problem of fMRI is that it measures neural activity indirectly through changes in regional blood flow. Thus, without careful correction for age differences in vasculature reactivity, differences in fMRI signals can be erroneously regarded as neuronal differences.
An important line of research focuses on controlling for noise in fMRI signals using additional baseline measures of vascular function. However, such methods have not been widely used, possibly because they are impractical to implement in studies of aging.
An alternative candidate for correction makes use of resting state fMRI measurements, which is easy to acquire in most fMRI experiments. While this method has been difficult to validate in the past, the unique combination of an impressive data set across 335 healthy volunteers over the lifespan, as part of the Cambridge Centre for Ageing and Neuroscience (CamCAN) project, allowed Dr. Kamen Tsvetanov and colleagues to probe the true nature of aging effects on resting state fMRI signal amplitude.
Their research showed that age differences in signal amplitude during a task are of a vascular, not neuronal, origin. They propose that their method can be used as a robust correction factor to control for vascular differences in fMRI studies of aging.
The study also challenged previous demonstrations of reduced brain activity in visual and auditory areas during simple sensorimotor tasks. Using conventional methods, the current study replicated these findings.
However, after correction, Tsvetanov et al. results show that it might be vascular health, not brain function, that accounts for most age-related differences in fMRI signal in sensory areas. Their results suggest that the age differences in brain activity may be overestimated in previous fMRI studies of aging.
Dr. Tsvetanov said: "There is a need to refine the practice of conducting fMRI. Importantly, this doesn't mean that studies lacking 'golden standard' calibration measures, such as large scale studies, patient studies or ongoing longitudinal studies are invalid. Instead, researchers should make use of available resting state data as a suitable alternative. These findings clearly show that without such correction methods, fMRI studies of the effects of age on cognition may misinterpret effect of age as a cognitive, rather than vascular, phenomena."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Kamen A. Tsvetanov, Richard N. A. Henson, Lorraine K. Tyler, Simon W. Davis, Meredith A. Shafto, Jason R. Taylor, Nitin Williams, Cam-CAN, James B. Rowe. The effect of ageing on fMRI: Correction for the confounding effects of vascular reactivity evaluated by joint fMRI and MEG in 335 adults. Human Brain Mapping, Published Online February 27 2015. doi: 10.1002/hbm.22768
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Catalyst Can Degrade Alzheimer's-Related Amyloid Peptide Under Near-Infrared LightNews
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Αβ) under near-infrared (NIR) light irradiation has been developed.READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018